Activity: Development of glenzocimab for the treatment of ischemic stroke and other thrombotic diseases, and a diagnostic test for stroke.
Sector: Biotechnology & Nutrition
Investment date: October 2019
Fund: Go Capital Amorçage 2
Activity: Development of glenzocimab for the treatment of ischemic stroke and other thrombotic diseases, and a diagnostic test for stroke.
Sector: Biotechnology & Nutrition
Investment date: October 2019
Fund: Go Capital Amorçage 2